Medication info
Dangsiga Jeong 5 mg (Dapagliflozin Propanediol Hydrate)

Dangsiga Jeong 5 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Korea HuTex Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets/bottle, 30 tablets/bottle, 28 tablets/box [7 tablets/Alu-Alu x 4]
Approval status
Active

MFDS item code 202203125 · Approved 2022.07.29 · Insurance code 649105610

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, including insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacologic treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Ingredients

Manufacturer
Korea HuTex Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be used as an adjunct to diet and exercise. It can be used either as monotherapy or in combination with other diabetes medications, and is also appropriately prescribed to patients with cardiovascular disease or risk factors. This helps improve blood sugar control and reduce the risk of cardiovascular events. This medication is used for the treatment of type 2 diabetes.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, including insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacologic treatment for diabetes, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablets should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with a history of hypersensitivity, type 1 diabetes mellitus, diabetic ketoacidosis, or patients undergoing dialysis. It should be administered cautiously in patients with reduced fluid volume or renal dysfunction, and care must be taken to evaluate and monitor fluid status and kidney function due to the risk of hypotension or acute kidney injury. The efficacy of blood sugar control varies depending on kidney function, so it is not recommended for blood sugar control purposes in patients with moderate or severe kidney impairment. Adverse reactions such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur while taking this medication, and patients should consult healthcare professionals immediately if any symptoms arise. Particular caution is needed for the elderly and patients taking diuretics due to a higher risk of hypotension and decreased fluid volume. Pregnant or breastfeeding women should avoid using this medication, and if pregnancy is confirmed, administration should be stopped immediately. This medication may increase the risk of hypoglycemia when used with insulin or sulfonylureas, so dosage adjustments of these medications may be necessary. During treatment, blood sugar levels as well as symptoms of ketoacidosis should be closely monitored, and healthcare professionals should be notified immediately if symptoms of dehydration or hypotension occur. Additionally, this medication may increase urinary output, leading to reduced fluid volume, so regular checks on fluid status are necessary. In case of overdose, there is no specific antidote, so appropriate symptomatic treatment should be provided. Patients should be cautious of hypoglycemic symptoms when driving or operating machinery. Finally, this medication has not been established for safety and efficacy in children, so it should not be used and must be kept out of reach of children.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, initial decrease in renal creatinine clearance during treatment, dyslipidemia, initial increase in serum creatinine during treatment, increased serum urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, paresthesia, cerebral infarction, nerve compression, urosepsis, acute pyelonephritis, chest pain, chronic gastritis, diverticulitis, intragastric air retention, frequent bowel movements, gastroenteritis, colon polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disease, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency incontinence, diabetic nephropathy, overactive bladder, microalbuminuria, stress incontinence, urinary hesitancy, urinary stones, abnormal urination, increased serum lactate, lymphocytopenia, vitamin D deficiency, increased appetite, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, herpes zoster, sinusitis, tonsillitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, toenail fungus, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, fatigue, chest discomfort, menorrhagia, genital rash, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweat dysregulation eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius to safely retain the medication's efficacy.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/bottle, 30 tablets/bottle, 28 tablets/box [7 tablets/Alu-Alu x 4]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.